Catalog No.
VVV19501
Species reactivity
Human papillomavirus type 6
Host species
Human
Isotype
IgG1
Clonality
Monoclonal
Target
Major capsid protein L1, L1
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
Q9W9C6
Applications
ELISA, Neutralization
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
Iv0005
A bioinformatics approach for identifying the probable cause of the cross-interaction of antibodies to the antigenic protein HPV16 L1 with the HPV6 L1 protein. PMID: 34950850
The Use of Both Therapeutic and Prophylactic Vaccines in the Therapy of Papillomavirus Disease. PMID: 32133000
The Synthesis of Main Capsid Protein of Anogenital Type HPV6 L1 in Plant Expression System on the Basis of Tomato Fruits. PMID: 34189649
Prophylactic HPV vaccination: past, present, and future. PMID: 26429676
The Use of the Antigenic Protein HPV6 L1 to Induce the Synthesis of Interferon, CD4 and CD8 T Lymphocytes, and Granzyme B in Blood and Splenocytes of Mice in Order to Develop a Broad Vaccine against Anogenital Papillomatoses. PMID: 34697740
Impact of an HPV6/11/16/18 L1 virus-like particle vaccine on progression to cervical intraepithelial neoplasia in seropositive women with HPV16/18 infection. PMID: 21491420
Multivalent human papillomavirus l1 DNA vaccination utilizing electroporation. PMID: 23536912
Human papillomavirus vaccines. PMID: 10712890
Developments in L2-based human papillomavirus (HPV) vaccines. PMID: 27889616
Binding antibody levels to vaccine (HPV6/11/16/18) and non-vaccine (HPV31/33/45/52/58) HPV antigens up to 7 years following immunization with either Cervarix® or Gardasil® vaccine. PMID: 35115194
Molecular cloning of a new variant of human papillomavirus type 6 isolated from a Chinese woman and expression of its L1 gene in E. coli--molecular cloning & expression of HPV6 gene. PMID: 1318719
Comparison of a VLP-based and GST-L1-based multiplex immunoassay to detect vaccine-induced HPV-specific antibodies in first-void urine. PMID: 32266996
Prophylactic human papillomavirus vaccines. PMID: 16670757
Chapter 16: Prophylactic human papillomavirus vaccines. PMID: 12807954
Currently approved prophylactic HPV vaccines. PMID: 19943762
Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles. PMID: 27147749
Humoral immune response recognizes a complex set of epitopes on human papillomavirus type 6 l1 capsomers. PMID: 16014913
Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. PMID: 8230414
Systematic review and meta-analysis of L1-VLP-based human papillomavirus vaccine efficacy against anogenital pre-cancer in women with evidence of prior HPV exposure. PMID: 24595046
Evaluation of human papillomavirus (HPV) genotyping assays using type-specific HPV L1 reference DNA. PMID: 33884570
Neutralization sites of human papillomavirus-6 relate to virus attachment and entry phase in viral infection. PMID: 31769733
Chimeric L1-L2 virus-like particles as potential broad-spectrum human papillomavirus vaccines. PMID: 19640991
Human papillomavirus antibody response following HAART initiation among MSM. PMID: 28121669
Cross-reactivity of antigens and antibodies belonging to different pathogenic types of human papillomaviruses. PMID: 29297125
Detection of anti-HPV11-L1 antibodies in immune sera from patients suffering from recurrent respiratory papillomatosis using ELISA. PMID: 20712486
Expression of human papillomavirus type 6 L1 and L2 isolated in China and self assembly of virus-like particles by the products. PMID: 12518224
Investigation of the Presence of DNA of Highly Pathogenic Human Papillomaviruses in Water Bodies of the Lake Baikal Natural Territory. PMID: 35932447
Development of a human papillomavirus type 6/11 vaccine candidate for the prevention of condyloma acuminatum. PMID: 30037483
Expression of the major capsid protein of human papillomavirus type 11 in Saccharomyces cerevisae. PMID: 8973339
HPV vaccines to prevent cervical cancer and genital warts: an update. PMID: 24606637
Development a scalable production process for truncated human papillomavirus type-6 L1 protein using WAVE Bioreactor and hollow fiber membrane. PMID: 26446387
Bacterially expressed human papillomavirus type 6 and 11 bivalent vaccine: Characterization, antigenicity and immunogenicity. PMID: 28483196
Melting profiles may affect detection of residual HPV L1 gene DNA fragments in Gardasil®. PMID: 24083601
Human Papillomavirus (HPV) L1 Serum Antibodies and the Risk of Subsequent Oral HPV Acquisition in Men: The HIM Study. PMID: 26931445
Global genomic diversity of human papillomavirus 6 based on 724 isolates and 190 complete genome sequences. PMID: 24741079
Phase II studies to select the formulation of a multivalent HPV L1 virus-like particle (VLP) vaccine. PMID: 25912208
For research use only. Not for human or drug use.
